OXT and obesity due to melanocortin 4 receptor deficiency: The latter assumption is supported by findings that acute OXT administration results in a stronger decrease in food intake in males with obesity as compared to males with normal weight [15], a pattern previously suggested to reflect a compensatory response of a OXT-sensitive system [37].